Literature DB >> 19781041

Preterm premature rupture of membranes, chorioamnion inflammatory scores and neonatal respiratory outcome.

V Zanardo1, S Vedovato, E Cosmi, P Litta, F Cavallin, D Trevisanuto, S Chiarelli.   

Abstract

OBJECTIVE: To evaluate whether histological chorioamnionitis (HCA), in the setting of preterm premature rupture of membranes (PPROM), affects infant respiratory outcome.
DESIGN: A prospective histological study on 287 consecutive placentas was performed in preterm infants (<or=32(+6) weeks gestation), categorised into four groups: according to the presence or absence of HCA, in the setting or in absence of PPROM.
SETTING: Neonatal intensive care unit, Department of Pediatrics, Padua University, Padua, Italy from January 2001 to December 2006.
RESULTS: Among the 287 NICU admitted preterm infants, 68/287 (23.6%) presented with HCA, 16/68 (23.5%) with a coexisting fetal inflammatory response, and 74/287 (25.7%) with PPROM. HCA was associated with a greater frequency of vaginal delivery (P < 0.0001), lower gestational age (P < 0.0001) and lower birth weight (P < 0.01). HCA had no effect on fetal lung maturation, however, it was a significant risk factor for CLD (RR; 95% CI 2.08; 1.30-3.33). HCA and the fetal inflammatory response were also significant risk factors for PPROM (RR; 95% CI 2.07; 1.42-3.03 and 2.64; 1.71-4.09 respectively). Conversely, HCA in the setting of PPROM failed to reveal any RDS protection or subtype CLD risk. Multivariate analysis demonstrated significant independent effects of presence of maternal HCA (P = 0.04), gestational age (P < 0.0001) and interaction HCA-gestational age (P = 0.04) on CLD development, regardless of the presence of fetal HCA or fetal HCA-gestational age interaction, PPROM or PPROM-gestational age interaction.
CONCLUSIONS: Histological chorioamnionitis is a significant PPROM and CLD risk factor, but it fails to provide any protection from RDS. HCA in the setting of PPROM also failed to reveal any RDS protection or subtype CLD risk.

Entities:  

Mesh:

Year:  2010        PMID: 19781041     DOI: 10.1111/j.1471-0528.2009.02358.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

1.  Respiratory Distress Syndrome in Infants Delivered via Cesarean from Mothers with Preterm Premature Rupture of Membranes: A Propensity Score Analysis.

Authors:  Mariko Nakahara; Shunji Goto; Eiji Kato; Atsuo Itakura; Satoru Takeda
Journal:  J Pregnancy       Date:  2020-07-31

2.  Prevalence and risk factors of chorioamnionitis in Dhaka, Bangladesh.

Authors:  G J Chan; M Silverman; M Zaman; A Murillo-Chaves; A Mahmud; A H Baqui; T K Boyd
Journal:  J Perinatol       Date:  2016-09-15       Impact factor: 2.521

3.  A Retrospective Study on the Risk of Respiratory Distress Syndrome in Singleton Pregnancies with Preterm Premature Rupture of Membranes between 24+0 and 36+6 Weeks, Using Regression Analysis for Various Factors.

Authors:  Anna Niesłuchowska-Hoxha; Wojciech Cnota; Bartosz Czuba; Aleksandra Ruci; Magdalena Ciaciura-Jarno; Agnieszka Jagielska; Dominik Wójtowicz; Rafał Kierach; Krzysztof Dąbrowski; Marcin Sidorowicz; Wioletta Skrzypulec-Plinta; Agata Wloch; Dariusz Borowski; Piotr Węgrzyn
Journal:  Biomed Res Int       Date:  2018-10-04       Impact factor: 3.411

4.  A clinical prediction rule for histological chorioamnionitis in preterm newborns.

Authors:  Jasper V Been; Sizzle F Vanterpool; Jasmijn D E de Rooij; G Ingrid J G Rours; René F Kornelisse; Martien C J M van Dongen; Christel J A W van Gool; Ronald R de Krijger; Peter Andriessen; Luc J I Zimmermann; Boris W Kramer
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

5.  Neonatal respiratory morbidity following exposure to chorioamnionitis.

Authors:  Amy Metcalfe; Sarka Lisonkova; Yasser Sabr; Amelie Stritzke; K S Joseph
Journal:  BMC Pediatr       Date:  2017-05-17       Impact factor: 2.125

6.  Neutrophil-lymphocyte ratio for the prediction of histological chorioamnionitis in cases of preterm premature rupture of membranes: a case-control study.

Authors:  Greta Balciuniene; Greta Kvederaite-Budre; Violeta Gulbiniene; Irena Dumalakiene; Rita Viliene; Ingrida Pilypiene; Grazina S Drasutiene; Diana Ramasauskaite
Journal:  BMC Pregnancy Childbirth       Date:  2021-09-27       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.